Shanghai RAAS Blood Products Co Ltd

Return on Assets, %

6.5

-40.3

Net income margin, %

31.7

-180

EBITDA margin, %

33

-168.2

Debt to Equity, %

0

3.2

Intangible assets and goodwill, %

15.3

0.2

Revenue CAGR 3Y, %

36.4

12.5

Total Equity change 1Y, %

0.9

-9

Revenue Y, % chg

14.1

0

P/E

22

31

P/BV

1.4

1.8

P/S

5.9

10.3

EV/S

5.3

7.5

EV/EBITDA

20.1

-1.6

Average Analyst recommendation

Buy

Buy

Forward P/E

17.5

21.4

Dividend Yield, %

0.4

1.1

Forward Dividend Yield, %

0.1

0.1

Expected dividend per share

0

0

Payout Ratio, %

9.8

0

Dividend Ex Date

2023-06-13